Trafficking protein particle complex subunit 1
CAT No: ta-219
Synonyms/Alias:Trafficking protein particle complex subunit 1 (123-133)
Trafficking protein particle complex subunit 1 (123-133) is a synthetic peptide fragment derived from the TRAPPC1 protein, a core component of the TRAPP (Transport Protein Particle) complex involved in intracellular vesicle trafficking. This peptide segment encompasses amino acid residues 123 to 133, representing a functionally relevant region within the larger protein structure. As a biochemical research tool, it offers unique opportunities to probe the molecular mechanisms underlying vesicle transport, protein-protein interactions, and the assembly dynamics of multisubunit complexes. Its structural specificity and defined sequence make it valuable for targeted studies in cell biology, molecular trafficking, and systems biochemistry.
Protein-protein interaction studies: The 123-133 peptide fragment of TRAPPC1 is particularly useful for dissecting the molecular interfaces involved in TRAPP complex assembly and function. By serving as a defined binding motif, it enables researchers to map interaction sites between TRAPPC1 and its partner proteins, facilitating detailed analyses via techniques such as pull-down assays, surface plasmon resonance, or co-immunoprecipitation. These studies contribute to a deeper understanding of how the TRAPP complex mediates vesicle tethering and fusion events in eukaryotic cells.
Vesicular trafficking mechanism research: As a segment derived from a key trafficking protein, this peptide is instrumental in elucidating the regulatory mechanisms of vesicle transport between organelles such as the endoplasmic reticulum and Golgi apparatus. Incorporation of the peptide into in vitro reconstitution systems or cell-free assays allows for the examination of its influence on vesicle docking, targeting specificity, and the recruitment of accessory factors. Such investigations provide essential insights into the orchestration of membrane trafficking pathways and the role of TRAPPC1 within these processes.
Antibody production and epitope mapping: The unique sequence of TRAPPC1 (123-133) is well-suited for use as an immunogen in the generation of sequence-specific antibodies. These antibodies can be applied to the detection and quantification of endogenous TRAPPC1 in complex biological samples, supporting both basic research and analytical workflows. Additionally, the peptide aids in epitope mapping studies, helping to define regions of antigenicity and inform the design of targeted immunoassays.
Phosphorylation and post-translational modification analysis: The defined nature of this peptide fragment allows for the controlled study of post-translational modifications, such as phosphorylation, acetylation, or ubiquitination, that may occur within the TRAPPC1 protein. By serving as a substrate in kinase assays or modification-specific binding studies, the peptide helps elucidate how such modifications impact TRAPP complex function, protein stability, or subcellular localization. This application is particularly valuable for understanding regulatory mechanisms at the molecular level.
Peptide-based inhibitor development: The TRAPPC1 (123-133) sequence provides a template for the rational design of peptide-based inhibitors or mimetics that can modulate protein interactions within the TRAPP complex. Screening of this fragment and its analogs may reveal lead compounds capable of selectively disrupting or stabilizing specific protein-protein interfaces, thereby offering tools for functional dissection of vesicle trafficking networks. Such studies have implications for advancing chemical biology approaches to dissect intracellular transport machinery.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.